Sawaf et al. showed that the ability of BTLA to inhibit T cell activation is suppressed in SLE and that BTLA dysfunction in lupus CD4+ T cells is associated with the disease activity [13]. This evidence concerns the gene CD4 and systemic lupus erythematosus.